Literature DB >> 29667118

ACMT Position Statement: Alternative or Contingency Countermeasures for Acetylcholinesterase Inhibiting Agents.

Andrew Stolbach1, Vikhyat Bebarta2, Michael Beuhler3, Shaun Carstairs4, Lewis Nelson5, Michael Wahl6, Paul M Wax7, Charles McKay8.   

Abstract

First responders and health care providers must prepare to provide care for patients poisoned by acetylcholinesterase (AchE) inhibitor chemical warfare agents or pesticides. However, pre-deployed medical countermeasures (MCMs) may not be sufficient due to production and delivery interruption, rapid depletion of contents during a response, expiration of MCM components, or lack of local availability of approved MCMs. To augment supplies of community-based and forward-deployed nerve agent countermeasures, the American College of Medical Toxicology (ACMT) supports several strategies: (1) The use of expired atropine, diazepam, and pralidoxime auto-injectors and vials if non-expired drugs are unavailable; and (2) Investigation, development, and identification of alternative countermeasures-commonly stocked drugs that are not approved for nerve agent poisoning but are in the same therapeutic class as approved drugs.

Entities:  

Keywords:  Acetylcholinesterase inhibitors; Atropine; Countermeasures; Expiration date; Pralidoxime

Mesh:

Substances:

Year:  2018        PMID: 29667118      PMCID: PMC6097966          DOI: 10.1007/s13181-018-0658-4

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  10 in total

1.  A role for ipratropium in chemical terrorism preparedness.

Authors:  Jeanmarie Perrone; Fred Henretig; Michael Sims; Michael Beers; Michael A Grippi
Journal:  Acad Emerg Med       Date:  2003-03       Impact factor: 3.451

2.  Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.

Authors:  Douglas B Murray; Michael Eddleston; Simon Thomas; Robert D Jefferson; Adrian Thompson; Mick Dunn; Daniel S Vidler; R Eddie Clutton; Peter G Blain
Journal:  Ann Emerg Med       Date:  2012-06-26       Impact factor: 5.721

Review 3.  Checklists for hazardous materials emergency preparedness.

Authors:  Stephen W Borron
Journal:  Emerg Med Clin North Am       Date:  2014-11-15       Impact factor: 2.264

4.  Antidote shortages in the USA: impact and response.

Authors: 
Journal:  J Med Toxicol       Date:  2015-03

Review 5.  Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis.

Authors:  Puneet Jain; Suvasini Sharma; Tarun Dua; Corrado Barbui; Rashmi Ranjan Das; Satinder Aneja
Journal:  Epilepsy Res       Date:  2016-02-16       Impact factor: 3.045

6.  Clinical and bioavailability studies of sublingually administered atropine sulfate.

Authors:  Sheetal Rajpal; Raisuddin Ali; Aseem Bhatnagar; Sujit Kumar Bhandari; Gaurav Mittal
Journal:  Am J Emerg Med       Date:  2010-02       Impact factor: 2.469

7.  Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers.

Authors:  Sheetal Rajpal; Gaurav Mittal; Ruchi Sachdeva; Mitrabasu Chhillar; Rashid Ali; Shyam Sunder Agrawal; Ravi Kashyap; Aseem Bhatnagar
Journal:  Environ Toxicol Pharmacol       Date:  2008-10-28       Impact factor: 4.860

8.  An atropine and glycopyrrolate combination reduces mortality in organophosphate poisoning.

Authors:  Regan Arendse; Elvis Irusen
Journal:  Hum Exp Toxicol       Date:  2009-10-22       Impact factor: 2.903

9.  Preparing for chemical terrorism: stability of injectable atropine sulfate.

Authors:  Joshua G Schier; Padinjarekuttu R Ravikumar; Lewis S Nelson; Michael B Heller; Mary Ann Howland; Robert S Hoffman
Journal:  Acad Emerg Med       Date:  2004-04       Impact factor: 3.451

10.  Comparison of the robustness and functionality of three adrenaline auto-injectors.

Authors:  Andreas Schwirtz; Harald Seeger
Journal:  J Asthma Allergy       Date:  2012-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.